151 related articles for article (PubMed ID: 3711929)
1. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Huff FJ; Maire JC; Growdon JH; Corkin S; Wurtman RJ
J Neurol Sci; 1986 Feb; 72(2-3):121-9. PubMed ID: 3711929
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ
J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304
[TBL] [Abstract][Full Text] [Related]
3. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
4. The significance of the activity of CSF cholinesterases in dementias.
Shen ZX
Med Hypotheses; 1996 Nov; 47(5):363-76. PubMed ID: 8951800
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
Bisso GM; Masullo C; Michalek H; Silveri MC; Pocchiari M
Life Sci; 1986 Feb; 38(6):561-7. PubMed ID: 3945178
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
9. Human cerebrospinal fluid acetylcholinesterase and butyrylcholinesterase. Evidence for identity between the serum and cerebrospinal fluid butyrylcholinesterase.
Rao RV; Gnanamuthu C; Balasubramanian AS
Clin Chim Acta; 1989 Aug; 183(2):135-45. PubMed ID: 2791303
[TBL] [Abstract][Full Text] [Related]
10. Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
Sirviö J; Soininen HS; Kutvonen R; Hyttinen JM; Helkala EL; Riekkinen PJ
J Neurol Sci; 1987 Nov; 81(2-3):273-9. PubMed ID: 3694232
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
Kawakatsu S; Morinobu S; Shinohara M; Totsuka S; Kobashi K
Biol Psychiatry; 1990 Sep; 28(5):387-400. PubMed ID: 1698467
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.
Elble R; Giacobini E; Scarsella GF
Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystonia.
Ruberg M; Villageois A; Bonnet AM; Rieger F; Agid Y; Fahn S
Adv Neurol; 1988; 50():211-3. PubMed ID: 3400494
[No Abstract] [Full Text] [Related]
15. Serum and CSF cholinesterase activity in various kinds of dementia.
Szilágyi AK; Németh A; Martini E; Lendvai B; Venter V
Eur Arch Psychiatry Neurol Sci; 1987; 236(5):309-11. PubMed ID: 3653153
[TBL] [Abstract][Full Text] [Related]
16. Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease.
Arendt T; Bigl V; Walther F; Sonntag M
Lancet; 1984 Jan; 1(8369):173. PubMed ID: 6140490
[No Abstract] [Full Text] [Related]
17. Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters.
Wester P; Eriksson S; Forsell A; Puu G; Adolfsson R
Acta Neurol Scand; 1988 Jan; 77(1):12-21. PubMed ID: 2451393
[TBL] [Abstract][Full Text] [Related]
18. [Some data on cholinesterases in the cerebrospinal fluid of the dog].
D'Angelo P; Scarsella G
Boll Soc Ital Biol Sper; 1979 Jun; 55(11):1067-71. PubMed ID: 549583
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
